Navigation Links
GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US
Date:4/1/2009

cancer."

About TYVERB(R)/TYKERB(R) (lapatinib)

Lapatinib is an oral small-molecule inhibitor of the HER2/ErbB2 tyrosine kinase receptor. Stimulation of HER2/ErbB2 is associated with cell proliferation and with multiple processes involved in tumor progression and metastases. Overexpression of these receptors has been reported in a variety of human tumors and is associated with poor prognosis and reduced overall survival.

Lapatinib, in combination with capecitabine, is approved in 74 countries. On March 13, 2007, the U.S. FDA approved lapatinib in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2/ErbB2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab. On June 10, 2008, the European Commission granted a conditional marketing authorization for lapatinib in all 27 European Union (EU) member states. Other countries in which lapatinib is approved for marketing include Australia, India, Brazil, Russia, Switzerland, Turkey, South Korea, Taiwan and others around the world. Registration dossiers for lapatinib have been filed in Canada, China, Japan, Mexico and a number of countries in Latin America, Middle East, Africa and Asia Pacific.

GSK in Oncology

GSK Oncology is dedicated to producing innovations in cancer that will make profound differences in the lives of patients. Through GSK's revolutionary 'bench to bedside' approach, we are transforming the way treatments are discovered and developed, resulting in one of the most robust pipelines in the oncology sector. Our worldwide research in oncology includes collaborations with more than 160 cancer centers. GSK is closing in on cancer from all sides with a new generation of patient-focused cancer treatments in prevention, supportive care, chemotherapy and targeted therapies.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
2. Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace
3. Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine)
4. Interleukin Genetics Submits Plan to Regain Compliance with Continued Listing Standards
5. STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter
6. TriServ Alliance Submits Final Bid for TRICARE South Region Contract
7. WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
8. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
9. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
10. SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
11. TriServ Alliance Submits Bid for TRICARE South Region Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... The Encino cosmetic dentist at ... and porcelain veneers. These restorations are an excellent ... and greater loss of healthy tooth tissue. They work ... flaws on the tooth. Encino dentist Dr. Mastour and ... ensure they offer the most appropriate treatment recommendations for ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, July ... a faltering sense of smell might signal the early ... smell test could spot who needs more extensive screening ... ability to identify odors was associated with the loss ... "We,re trying to be able to diagnose Alzheimer,s ...
(Date:7/14/2014)... HealthDay Reporter MONDAY, July ... linked to multiple health issues, but dementia isn,t one of ... widowhood may even delay dementia, the researchers found. "For ... was associated with a later age of developing full-blown dementia ... Bryan Woodruff. Woodruff, an assistant professor of neurology ...
(Date:7/14/2014)... Connecticut (PRWEB) July 14, 2014 ... is celebrating its Grand Opening on Monday, July ... Connecticut 06830. The celebration will last all week ... all new patients. Everyone is welcomed to attend. ... M.D. who provides physician-administered skincare, anti-aging, weight loss ...
(Date:7/14/2014)... Huntington Beach, CA (PRWEB) July 14, 2014 ... of thousands of people undergo plastic surgery to reduce ... hit the market, however, eliminates the need to go ... mouth guard that works the jaw muscles, therefore tightening ... of having two chins. , Jawflex is used for ...
Breaking Medicine News(10 mins):Health News:Encino Esthetic Dental Group is Now Offering Lumineers and Porcelain Veneers 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 2Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 3Health News:Jawflex | Double Chin Exercise for Double Chin Reduction 2
... based on computerized simulation models suggests that the lifetime risk ... tomography (CT scan) coronary angiography varies widely, with the risk ... disease (CAD) is the leading cause of death in men ... 5 deaths, and a major cause of health care expenditures, ...
... reveals abnormal cells the woman will be offered colposcopy, ... cervix with a special microscope. Many women find the ... of anxiety before and during colposcopy. ,,Researchers ... trials that involved a total of 1441 women and ...
... The U.S. Food and Drug Administration (FDA) has approved the ... degenerative disc disease , one of the most common causes ... approved, the Prestige Cervical Disc, is manufactured by Medtronic Sofamor ... disc means that people with cervical degenerative disc disease now ...
... law to curb smoking to secure peoples' rights to the ... much committed towards implementing a comprehensive anti-tobacco law to reduce ... children and adolescents," Ali bin Shukur, Under-secretary of the Ministry ... ,A draft bill on smoking is being deliberated at ...
... of researchers have found that combining pre-operative chemotherapy and ... six percent when compared with surgery alone. ... the MRC Clinical Trials Unit in London after they ... from seven of these trials were available from trial ...
... a plan for coping with a pandemic flu outbreak, the ... disease outbreak and track its progress across the country. ... the borders if a pandemic flu outbreak occurs somewhere in ... president for biodefense:The reality is that there are tremendous challenges ...
Cached Medicine News:Health News:CT Scan Radiations may Lead to Cancer 2Health News:FDA Approves First Artificial Cervical Disc 2Health News:Chemotherapy Better for Non Small Cell Lung cancer 2Health News:Americas Preparations For Flu Outbreak Still Incomplete 2
(Date:7/11/2014)... , July 11, 2014 According ... Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and ... Trends and Forecast, 2013-2019" the global endoscopy devices market ... is expected to grow at a CAGR of 6.8% ... of USD 36.9 billion in 2019. Browse ...
(Date:7/11/2014)... , July 11, 2014  Veran Medical ... announced today the positive, cost-effective final results ... SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy ... percutaneous approach to biopsy when a traditional ... and physicians experience positive financial outcomes when ...
(Date:7/11/2014)... , July 11, 2014 Neurelis, Inc. ... ("Biotie") to end the option held by Biotie to ... further development of NRL-1 (intranasal diazepam) for pediatric and ... Over the past year, Biotie has advanced the ... preparation for the pivotal clinical work required for NDA ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Veran Medical Publishes Lung Cancer Patient Management Study 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3
... ALEXANDRIA, Va., Sept. 1 The ... of a new website, www.PharmacyMatching.com to ... their pharmacy, existing owners who desire additional stores ... become a pharmacy owner. (Logo: ...
... Sept. 1 Eli Lilly and Company (NYSE: ... for the Federal Circuit has affirmed a prior ruling by ... that the company,s method-of-use patents for Evista® (raloxifene HCl tablets) ... U.S. through March of 2014. "We are pleased ...
Cached Medicine Technology:NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers 2NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers 3U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014 2
RIA kit for the quantitative determination of autoantibodies to thyroid peroxidase (TPO) in serum....
For the quantitative determination of Estradiol (E2) concentration in human serum or plasma....
... quantitative determination of Estradiol (E2) concentration in human ... steroid hormone with a phenolic A ring. ... 272.4. It is the most potent natural ... in smaller amounts by the adrenal cortex, and ...
... Cardiac troponin I (cTnI) has been ... presenting to Emergency Departments (ED) with chest ... is diagnosed when blood levels of sensitive ... the MB isoenzyme of creatine kinase (CK-MB), ...
Medicine Products: